PI
DFTX

PEAK6 Investments’s Definium Therapeutics DFTX Stock Holding History

PEAK6 Investments’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$35.4K Sell
6,223
-19,477
-76% -$135K ﹤0.01% 3156
2024
Q2 		$185K Buy
25,700
+10,246
+66% +$89.6K ﹤0.01% 2795
2024
Q1 		$145K Buy
+15,454
New +$88.1K ﹤0.01% 3216

Other funds holding DFTX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Investments's DFTX Position: Q3 2024 in Review

PEAK6 Investments reduced its Definium Therapeutics (DFTX) stake by 76% in Q3 2024, selling an estimated $135K and leaving 6,223 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3156.

PEAK6 Investments first reported a position in DFTX in Q1 2024 and has held it in 3 quarters since. The position peaked at $185K in Q2 2024. 157 funds tracked by Wall St. Rank hold DFTX as of Q3 2024.

  • PEAK6 Investments held 6,223 shares of Definium Therapeutics worth $35.4K as of Q3 2024.
  • PEAK6 Investments sold 19,477 Definium Therapeutics shares in Q3 2024, an estimated $135K.
  • Definium Therapeutics made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3156 holding.
  • PEAK6 Investments first reported a position in Definium Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • PEAK6 Investments's Definium Therapeutics position peaked at $185K in Q2 2024.
  • 157 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.